Events

Horizon Europe Cluster 6 & Missions / EU Matchmaking
MAR
Tue
25

This was 8 months ago

Location

Metz, France

Programmes
Agro-Food, Environment Missions

Horizon Europe Cluster 6 & Missions - Conference & Bilateral/B2B meetings

To pave the way for future Horizon Europe Cluster 6 & EU Missions calls 2025, Enterprise Europe Network (EEN) of Grand Est Développement (Grand E-Nov+) in close partnership with cross-border National Contact Points (NCPs) Networks and EEN from Wallonia and Luxembourg, we prepared this unique Matchmaking event:

  • 1 Plenary session: keep up to date with the latest news
  • 4 Thematic parallel workshops with pitching sessions: present your project idea, and expertise and be visible
  • 480 B2B meetings: build connections, initiate contacts with potential partners

For more information and to register for this event, please access its dedicated page via this link. 

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.